Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
7.76 USD
2.87 B USD
21.90 B USD
129.24 M
About Merck KGaA
Sector
Industry
CEO
Belén Garijo López
Website
Headquarters
Darmstadt
Founded
1995
ISIN
DE0006599905
FIGI
BBG000P3VYP9
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
M
XS249102938
Merck Financial Services GmbH 2.375% 15-JUN-2030Yield to maturity
2.89%
Maturity date
Jun 15, 2030
M
XS210293205
Merck Financial Services GmbH 0.5% 16-JUL-2028Yield to maturity
2.36%
Maturity date
Jul 16, 2028
M
XS249102920
Merck Financial Services GmbH 1.875% 15-JUN-2026Yield to maturity
2.28%
Maturity date
Jun 15, 2026
See all MKGAF bonds
Curated watchlists where MKGAF is featured.
Frequently Asked Questions
The current price of MKGAF is 129.90 USD — it has decreased by −0.08% in the past 24 hours. Watch Merck KGaA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Merck KGaA stocks are traded under the ticker MKGAF.
MKGAF stock has risen by 2.69% compared to the previous week, the month change is a −1.02% fall, over the last year Merck KGaA has showed a −28.84% decrease.
We've gathered analysts' opinions on Merck KGaA future price: according to them, MKGAF price has a max estimate of 222.14 USD and a min estimate of 118.16 USD. Watch MKGAF chart and read a more detailed Merck KGaA stock forecast: see what analysts think of Merck KGaA and suggest that you do with its stocks.
MKGAF reached its all-time high on Dec 30, 2021 with the price of 264.40 USD, and its all-time low was 18.25 USD and was reached on Jul 29, 2002. View more price dynamics on MKGAF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MKGAF stock is 3.43% volatile and has beta coefficient of 0.73. Track Merck KGaA stock price on the chart and check out the list of the most volatile stocks — is Merck KGaA there?
Today Merck KGaA has the market capitalization of 56.04 B, it has increased by 0.46% over the last week.
Yes, you can track Merck KGaA financials in yearly and quarterly reports right on TradingView.
Merck KGaA is going to release the next earnings report on Nov 13, 2025. Keep track of upcoming events with our Earnings Calendar.
MKGAF earnings for the last quarter are 2.38 USD per share, whereas the estimation was 2.52 USD resulting in a −5.52% surprise. The estimated earnings for the next quarter are 2.46 USD per share. See more details about Merck KGaA earnings.
Merck KGaA revenue for the last quarter amounts to 6.19 B USD, despite the estimated figure of 6.26 B USD. In the next quarter, revenue is expected to reach 6.20 B USD.
MKGAF net income for the last quarter is 768.05 M USD, while the quarter before that showed 795.16 M USD of net income which accounts for −3.41% change. Track more Merck KGaA financial stats to get the full picture.
Yes, MKGAF dividends are paid annually. The last dividend per share was 2.51 USD. As of today, Dividend Yield (TTM)% is 2.01%. Tracking Merck KGaA dividends might help you take more informed decisions.
Merck KGaA dividend yield was 1.57% in 2024, and payout ratio reached 34.44%. The year before the numbers were 1.53% and 33.87% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 23, 2025, the company has 62.56 K employees. See our rating of the largest employees — is Merck KGaA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Merck KGaA EBITDA is 7.63 B USD, and current EBITDA margin is 29.15%. See more stats in Merck KGaA financial statements.
Like other stocks, MKGAF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Merck KGaA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Merck KGaA technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Merck KGaA stock shows the sell signal. See more of Merck KGaA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.